Lawsuit Overview
August 10, 2020 - An investor in shares of MEI Pharma, Inc. (NASDAQ: MEIP) filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by MEI Pharma, Inc. in connection with certain allegedly false and misleading statements made between August 2, 2017, and July 1, 2020. San Diego, CA based MEI Pharma, Inc., a l...
You must register (for free) or login to view the entire case.